Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ranju Baral

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
BMC Medicine|April 2, 2023
Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspectiveRachel Wittenauer, Clint Pecenka, Ranju Baral
BMJ Open|April 25, 2021
Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort modelRanju Baral, Deborah Higgins, Katie Regan, et al.
Public Health Nutrition|December 22, 2017
Using pre- and post-survey instruments in interventions: determining the random response benchmark and its implications for measuring effectivenessGeorge C Davis, Ranju Baral, Thomas Strayer, et al.
Journal of Nutrition Education and Behavior|December 6, 2012
Using national data to estimate average cost effectiveness of EFNEP outcomes by state/territoryRanju Baral, George C Davis, Stephanie Blake, et al.
Plos One|August 21, 2020
Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverageRanju Baral, Jessica Fleming, Sadaf Khan, et al.
BMC Public Health|May 7, 2020
Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimatesRanju Baral, Justice Nonvignon, Frédéric Debellut, et al.
Plos One|June 25, 2024
The cost of typhoid illness in low- and middle-income countries, a scoping review of the literatureFrederic Debellut, Alena Friedrich, Ranju Baral, et al.
BMC Medicine|April 10, 2023
Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countriesSarwat Mahmud, Ranju Baral, Colin Sanderson, et al.
Journal of the Pediatric Infectious Diseases Society|December 21, 2020
Estimating the Economic Impact of Respiratory Syncytial Virus and Other Acute Respiratory Infections Among Infants Receiving Care at a Referral Hospital in MalawiRanju Baral, Ivan Mambule, Elisabeth Vodicka, et al.
Vaccine|June 27, 2020
The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two modelsRanju Baral, Xiao Li, Lander Willem, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
BMC Medicine|April 2, 2023
Cost of childhood RSV management and cost-effectiveness of RSV interventions: a systematic review from a low- and middle-income country perspectiveRachel Wittenauer, Clint Pecenka, Ranju Baral
BMJ Open|April 25, 2021
Impact and cost-effectiveness of potential interventions against infant respiratory syncytial virus (RSV) in 131 low-income and middle-income countries using a static cohort modelRanju Baral, Deborah Higgins, Katie Regan, et al.
Public Health Nutrition|December 22, 2017
Using pre- and post-survey instruments in interventions: determining the random response benchmark and its implications for measuring effectivenessGeorge C Davis, Ranju Baral, Thomas Strayer, et al.
Journal of Nutrition Education and Behavior|December 6, 2012
Using national data to estimate average cost effectiveness of EFNEP outcomes by state/territoryRanju Baral, George C Davis, Stephanie Blake, et al.
Plos One|August 21, 2020
Inferring antenatal care visit timing in low- and middle-income countries: Methods to inform potential maternal vaccine coverageRanju Baral, Jessica Fleming, Sadaf Khan, et al.
BMC Public Health|May 7, 2020
Cost of illness for childhood diarrhea in low- and middle-income countries: a systematic review of evidence and modelled estimatesRanju Baral, Justice Nonvignon, Frédéric Debellut, et al.
Plos One|June 25, 2024
The cost of typhoid illness in low- and middle-income countries, a scoping review of the literatureFrederic Debellut, Alena Friedrich, Ranju Baral, et al.
BMC Medicine|April 10, 2023
Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countriesSarwat Mahmud, Ranju Baral, Colin Sanderson, et al.
Journal of the Pediatric Infectious Diseases Society|December 21, 2020
Estimating the Economic Impact of Respiratory Syncytial Virus and Other Acute Respiratory Infections Among Infants Receiving Care at a Referral Hospital in MalawiRanju Baral, Ivan Mambule, Elisabeth Vodicka, et al.
Vaccine|June 27, 2020
The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two modelsRanju Baral, Xiao Li, Lander Willem, et al.
Pageof 5